Motley Fool Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$238K Sell
476
-32,517
-99% -$15.6M 3.62% 14
2026
Q1
$16.2M Sell
32,993
-12,492
-27% -$6.78M 1.83% 13
2025
Q4
$26.4M Sell
45,485
-8,126
-15% -$4.6M 2.04% 11
2025
Q3
$26M Buy
53,611
+29,697
+124% +$13.8M 1.76% 13
2025
Q2
$9.7M Sell
23,914
-2,955
-11% -$1.24M 0.59% 59
2025
Q1
$13.4M Sell
26,869
-1,966
-7% -$1.06M 0.79% 38
2024
Q4
$15.2M Sell
28,835
-4,382
-13% -$2.41M 0.78% 37
2024
Q3
$20.5M Sell
33,217
-1,967
-6% -$1.16M 1.03% 28
2024
Q2
$19.3M Sell
35,184
-1,244
-3% -$713K 0.99% 30
2024
Q1
$21.2M Buy
36,428
+16,487
+83% +$9.25M 1.09% 25
2023
Q4
$10.6M Sell
19,941
-1,167
-6% -$565K 0.56% 58
2023
Q3
$10.7M Sell
21,108
-491
-2% -$262K 0.62% 50
2023
Q2
$11.3M Buy
+21,599
New +$11.7M 0.66% 47

Other funds holding TMO

Motley Fool Wealth Management's TMO Position: Q2 2026 in Review

Motley Fool Wealth Management reduced its Thermo Fisher Scientific (TMO) stake by 99% in Q2 2026, selling an estimated $15.6M and leaving 476 shares worth $238K. The position accounts for 3.62% of the portfolio, ranked #14.

Motley Fool Wealth Management first reported a position in TMO in Q2 2023 and has held it in 13 quarters since. The position peaked at $26.4M in Q4 2025. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Motley Fool Wealth Management held 476 shares of Thermo Fisher Scientific worth $238K as of Q2 2026.
  • Motley Fool Wealth Management sold 32,517 Thermo Fisher Scientific shares in Q2 2026, an estimated $15.6M.
  • Thermo Fisher Scientific made up 3.62% of Motley Fool Wealth Management's portfolio in Q2 2026, its #14 holding.
  • Motley Fool Wealth Management first reported a position in Thermo Fisher Scientific in Q2 2023 and has held it in 13 quarters since.
  • Motley Fool Wealth Management's Thermo Fisher Scientific position peaked at $26.4M in Q4 2025.
  • 2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Motley Fool Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.